LabelRx

Terms of Service

These are the terms under which you may use LabelRx (the iOS app and the marketing pages at bioturd.com/labelrx).

1. Intended audience — licensed clinicians only

LabelRx is a reference tool for licensed healthcare professionals: pharmacists, physicians, advanced-practice nurses, physician assistants, residents, pharmacy and medical students operating under supervision, and other clinicians authorized to prescribe, dispense, or administer medications in their jurisdiction. The app is not intended for consumers seeking medication advice.

2. Not clinical decision support — not FDA-cleared

LabelRx is not a medical device and is not cleared or authorized by the FDA (or any other regulator) as a clinical decision support tool, diagnostic aid, or therapeutic device. Nothing in the app — including drug labels, dose calculators, interaction displays, substitution suggestions, therapeutic equivalence codes, pregnancy or lactation guidance, pharmacogenomic annotations, or clinical-trial summaries — constitutes a prescription, a recommendation to prescribe, or a substitute for the independent clinical judgment of a qualified licensed professional.

You must always verify any information in LabelRx against the current FDA-approved prescribing information, authoritative references such as Lexicomp or Micromedex, your institution's formulary and protocols, and your own clinical judgment before making any prescribing, dispensing, counseling, or administration decision. By using LabelRx, you accept full responsibility for clinical decisions made in your practice.

3. Data sources and accuracy

LabelRx aggregates publicly available data from FDA DailyMed, openFDA (FDA labels, adverse events, recalls, shortages), the FDA Orange Book, ClinicalTrials.gov, NIH RxNorm/RxNav, and the Clinical Pharmacogenetics Implementation Consortium (CPIC), among other public sources. Although we pull from authoritative primary sources, we cannot guarantee that data in the app is complete, current, or free of parsing errors. Source feeds may experience delays, format changes, or omissions, and our automated label parser may misinterpret formatting in any given label.

In particular:

4. Not a substitute for the FDA-approved label

The FDA-approved prescribing information (the product's current package insert, available from DailyMed) is the definitive source. LabelRx summarizes and re-presents that information but is not a replacement for it. For any prescribing, dispensing, or administration decision, consult the current full prescribing information.

5. Acceptable use

You may use LabelRx for personal and professional reference in your practice. You may not:

6. Intellectual property

FDA drug labels, Orange Book data, FAERS reports, CPIC guidelines, and ClinicalTrials.gov records are U.S. government public-domain or non-copyrighted data. Third-party references (Lexicomp, Micromedex, etc.) are the property of their owners and are not redistributed by this app. LabelRx's branding, design, type system, compiled database structure, and original summary framing are our property.

7. Disclaimers and indemnification

The service is provided "as is" without warranties of any kind, express or implied, including merchantability, fitness for a particular purpose, non-infringement, or fitness for clinical use. We do not warrant that the service will be uninterrupted, error-free, timely, or suitable for any clinical purpose.

You agree to indemnify and hold harmless MEAS Partners, LLC and its operators from any claim, loss, or damage arising from your use of LabelRx, including any clinical decision or patient outcome influenced by information you accessed through the app.

8. Limitation of liability

To the maximum extent permitted by law, MEAS Partners, LLC and its operators are not liable for any direct, indirect, incidental, consequential, special, or punitive damages — including adverse patient outcomes, medication errors, allegations of professional negligence, lost profits, or business interruption — arising from your use of the service. Your sole remedy is to stop using the service.

9. Changes to the service

We may change, suspend, or discontinue the service at any time, including adding or removing data sources, calculators, or features, or changing how specific data is surfaced in the interface.

10. Governing law

These terms are governed by the laws of the State of New York, United States, without regard to conflict-of-laws principles, except as provided in section 12 below for consumers resident in the European Economic Area, the United Kingdom, or Switzerland. Any disputes arising under these terms shall be resolved in the state or federal courts located in New York.

11. Trader information and EU point of contact

For the purposes of Article 14a of the EU Consumer Rights Directive (as amended) and Articles 11 and 12 of the EU Digital Services Act (Regulation (EU) 2022/2065):

LabelRx does not host, store, or publicly disseminate user-generated content, and accordingly the DSA's content-moderation, notice-and-action, and transparency-reporting obligations applicable to "online platforms" (Articles 16 and 24 of the DSA) do not apply to this service.

12. Consumers in the EU/EEA, UK, and Switzerland

If you are a consumer resident in the European Economic Area, the United Kingdom, or Switzerland, nothing in these terms — including the indemnification and limitation-of-liability provisions in sections 7 and 8 and the governing-law clause in section 10 — limits, excludes, or overrides any statutory right you have under mandatory consumer-protection law in your country of residence that cannot be derogated from by agreement. You retain the right to bring proceedings before the courts of your country of residence under the applicable consumer-protection rules. Where any provision of these terms conflicts with such a mandatory right, that provision is, to the minimum extent necessary, disapplied as to you. Nothing in this section limits the clinical-use disclaimers in sections 1 through 4, which reflect the fundamental nature of the service rather than a waiver of statutory rights.

13. Contact

Questions about these terms: hello@bioturd.com.

Last updated: April 23, 2026